Valuation Imexpharm Corporation

Stocks

End-of-day quote Ho Chi Minh S.E. Other stock markets 20/07/2026			5-day change	1st Jan Change
37,650.00 ^VND	-3.71%		-8.62%	-28.29%

07-02	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026	CI
07-01	Imexpharm Corporation Announces Management and Committee Changes, Effective June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,798,437	-
Change	-	-22.62%	-1.28%	82.69%	11.7%	-28.29%	-
Enterprise Value (EV)	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,798,437	5,798,437
Change	-	-22.62%	-1.28%	82.69%	11.7%	-28.29%	0%
P/E	29.9x	17.2x	15.6x	24.3x	26.6x	16.3x	15.1x
PBR	2.89x	2.11x	1.9x	3.32x	-	2.31x	2.12x
PEG	-	0.5x	1.68x	1.4x	11.68x	1x	1.78x
Capitalization / Revenue	4.1x	2.44x	1.99x	3.28x	3.31x	2.18x	2.01x
EV / Revenue	0x	0x	0x	0x	0x	2.18x	2.01x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	11.8x	10.9x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	649.4	-	-	500	-	1,000	1,000
Rate of return	1.93%	-	-	1.06%	-	2.66%	2.66%
EPS ²	1,126	1,513	1,653	1,932	1,976	2,304	2,499
Distribution rate	57.7%	-	-	25.9%	-	43.4%	40%
Net sales ¹	1,266,597	1,643,707	1,994,037	2,205,120	2,441,085	2,659,000	2,881,000
EBITDA	299,271	-	457,049	521,703	-	-	-
EBIT ¹	234,475	300,992	374,407	403,285	445,003	490,000	532,000
Net income ¹	189,095	233,964	299,556	320,862	349,138	394,000	428,000
Net Debt	-	-	-	-	-	-	-
Reference price ²	33,679.65	26,060.61	25,727.27	47,000.00	52,500.00	37,650.00	37,650.00
Nbr of stocks (in thousands)	154,011	154,011	154,007	154,009	154,009	154,009	-
Announcement Date	20/01/22	17/01/23	19/01/24	20/01/25	20/01/26	-	-

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IMEXPHARM CORPORATION	16.97x	-	-	-	229M
ELI LILLY AND COMPANY	35.04x	12.53x	26.21x	0.57%	1,051B
JOHNSON & JOHNSON	27.19x	6.2x	16.98x	2.12%	609B
ABBVIE INC.	33.15x	7.52x	15.43x	2.7%	450B
ROCHE HOLDING AG	17.85x	4.43x	10.91x	3%	330B
NOVARTIS AG	21.66x	5.55x	13.44x	2.84%	284B
ASTRAZENECA PLC	21.16x	4.46x	12.34x	1.97%	263B
NOVO NORDISK A/S	14.45x	5.41x	11.15x	3.44%	223B
AMGEN INC.	24.02x	6.35x	11.22x	2.75%	198B
GILEAD SCIENCES, INC.	-48.37x	5.78x	31.95x	2.42%	167B
Average	16.31x	6.47x	16.62x	2.42%	357.53B
Weighted average by Cap.	24.01x	7.82x	18.33x	2%